Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Subacute myopathy during omeprazole therapy.

Literature DB >> 1355231

Subacute myopathy during omeprazole therapy.

F J Garrote, C Lacambra, T del Ser, B García Díaz, G Obeso, J Solís.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Omeprazole

Year: 1992 PMID： 1355231 DOI： 10.1016/0140-6736(92)92205-t

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.

Authors: R M Martin; N R Dunn; S Freemantle; S Shakir
Journal: Br J Clin Pharmacol Date: 2000-10 Impact factor: 4.335

Review 2. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?

Authors: David W J Clark; Johanna Strandell
Journal: Eur J Clin Pharmacol Date: 2006-04-22 Impact factor: 2.953

3. Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database.

Authors: Alice Capogrosso Sansone; Irma Convertino; Maria Teresa Galiulo; Stefano Salvadori; Stefania Pieroni; Tamara Knezevic; Stefania Mantarro; Alessandra Marino; Manfred Hauben; Corrado Blandizzi; Marco Tuccori
Journal: Drug Saf Date: 2017-10 Impact factor: 5.606

4. Treatment of refractory ulcerative oesophagitis with omeprazole.

Authors: P Alliët; M Raes; P Gillis; M Callewaert; A Zimmermann
Journal: Arch Dis Child Date: 1993-04 Impact factor: 3.791

Review 5. Toxic myopathies.

Authors: Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal: Neurol Clin Date: 2014-08 Impact factor: 3.806

Subacute myopathy during omeprazole therapy.

1. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.

Review 2. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?

3. Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database.

4. Treatment of refractory ulcerative oesophagitis with omeprazole.

Review 5. Toxic myopathies.

Review 6. A comparative overview of the adverse effects of antiulcer drugs.

7. Transmucosal gastric leak induced by proton pump inhibitors.

Review 8. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.